F-STAR THERAPEUTICS INC (FSTX)

US30315R1077 - Common Stock

7.12  0 (0%)

After market: 7.12 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
21.18M21.17M11.26M0.000.00
Operating Expenses
57.93M51.88M33.64M33.02M28.47M
Research and Development
34.65M28.75M14.13M23.27M19.75M
Selling, General, and Administrative Expenses
23.28M23.13M19.51M9.75M8.72M
Operating Income
-36.75M-30.71M-22.39M-33.02M-28.47M
Interest Income/Expense
-8.68M-255.00KN/A710.00K1.00M
Other Income/Expense
118.00K-686.00K-3.24M8.21M4.62M
Non Recurring Items
N/AN/A0.00N/AN/A
Income Before Taxes
-45.31M-31.66M-25.62M-24.10M-22.85M
Income Tax
-562.00K-372.00K0.00N/AN/A
Net Income
-44.75M-31.28M-25.62M-24.10M-22.85M
EBITDA
-36.08M-30.07M-21.25M-32.66M-28.18M
 
Per Share Data
EPS Diluted Total Ops
-2.07-1.88-9.69-5.86-6.36
Non GAAP EPS
-1.81-2.01-6.54-5.88-6.36
 
Statistics
Profit Margin
-211.32%-147.79%-227.53%N/AN/A
Operating Profit Margin
-173.56%-145.10%-198.85%N/AN/A

All data in USD

Charts